These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

300 related items for PubMed ID: 18398894

  • 1. Clinical role of calprotectin assay in determining histological relapses in children affected by inflammatory bowel diseases.
    Diamanti A, Colistro F, Basso MS, Papadatou B, Francalanci P, Bracci F, Muraca M, Knafelz D, De Angelis P, Castro M.
    Inflamm Bowel Dis; 2008 Sep; 14(9):1229-35. PubMed ID: 18398894
    [Abstract] [Full Text] [Related]

  • 2. Fecal calprotectin is useful in predicting disease relapse in pediatric inflammatory bowel disease.
    Walkiewicz D, Werlin SL, Fish D, Scanlon M, Hanaway P, Kugathasan S.
    Inflamm Bowel Dis; 2008 May; 14(5):669-73. PubMed ID: 18240279
    [Abstract] [Full Text] [Related]

  • 3. Low fecal calprotectin predicts sustained clinical remission in inflammatory bowel disease patients: a plea for deep remission.
    Mooiweer E, Severs M, Schipper ME, Fidder HH, Siersema PD, Laheij RJ, Oldenburg B.
    J Crohns Colitis; 2015 Jan; 9(1):50-5. PubMed ID: 25518048
    [Abstract] [Full Text] [Related]

  • 4. Does fecal calprotectin predict short-term relapse after stopping TNFα-blocking agents in inflammatory bowel disease patients in deep remission?
    Molander P, Färkkilä M, Ristimäki A, Salminen K, Kemppainen H, Blomster T, Koskela R, Jussila A, Rautiainen H, Nissinen M, Haapamäki J, Arkkila P, Nieminen U, Kuisma J, Punkkinen J, Kolho KL, Mustonen H, Sipponen T.
    J Crohns Colitis; 2015 Jan; 9(1):33-40. PubMed ID: 25052347
    [Abstract] [Full Text] [Related]

  • 5. Rapid fecal calprotectin level assessment and the SIBDQ score can accurately detect active mucosal inflammation in IBD patients in clinical remission: a prospective study.
    Voiosu T, Benguş A, Dinu R, Voiosu AM, Bălănescu P, Băicuş C, Diculescu M, Voiosu R, Mateescu B.
    J Gastrointestin Liver Dis; 2014 Sep; 23(3):273-8. PubMed ID: 25267955
    [Abstract] [Full Text] [Related]

  • 6. Effectiveness and cost-effectiveness of measuring fecal calprotectin in diagnosis of inflammatory bowel disease in adults and children.
    Yang Z, Clark N, Park KT.
    Clin Gastroenterol Hepatol; 2014 Feb; 12(2):253-62.e2. PubMed ID: 23883663
    [Abstract] [Full Text] [Related]

  • 7. Fecal calprotectin measurement is a marker of short-term clinical outcome and presence of mucosal healing in patients with inflammatory bowel disease.
    Kostas A, Siakavellas SI, Kosmidis C, Takou A, Nikou J, Maropoulos G, Vlachogiannakos J, Papatheodoridis GV, Papaconstantinou I, Bamias G.
    World J Gastroenterol; 2017 Nov 07; 23(41):7387-7396. PubMed ID: 29151692
    [Abstract] [Full Text] [Related]

  • 8. Fecal calprotectin: a quantitative marker of colonic inflammation in children with inflammatory bowel disease.
    Fagerberg UL, Lööf L, Lindholm J, Hansson LO, Finkel Y.
    J Pediatr Gastroenterol Nutr; 2007 Oct 07; 45(4):414-20. PubMed ID: 18030206
    [Abstract] [Full Text] [Related]

  • 9. Fecal calprotectin levels in children is more tightly associated with histological than with macroscopic endoscopy findings.
    Hradsky O, Ohem J, Mitrova K, Durilova M, Kotalova R, Nevoral J, Kolho KL, Bronsky J.
    Clin Lab; 2014 Oct 07; 60(12):1993-2000. PubMed ID: 25651733
    [Abstract] [Full Text] [Related]

  • 10. Fecal S100A12 and fecal calprotectin as noninvasive markers for inflammatory bowel disease in children.
    Sidler MA, Leach ST, Day AS.
    Inflamm Bowel Dis; 2008 Mar 07; 14(3):359-66. PubMed ID: 18050298
    [Abstract] [Full Text] [Related]

  • 11. Faecal calprotectin as reliable non-invasive marker to assess the severity of mucosal inflammation in children with inflammatory bowel disease.
    Canani RB, Terrin G, Rapacciuolo L, Miele E, Siani MC, Puzone C, Cosenza L, Staiano A, Troncone R.
    Dig Liver Dis; 2008 Jul 07; 40(7):547-53. PubMed ID: 18358796
    [Abstract] [Full Text] [Related]

  • 12. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease.
    D'Haens G, Ferrante M, Vermeire S, Baert F, Noman M, Moortgat L, Geens P, Iwens D, Aerden I, Van Assche G, Van Olmen G, Rutgeerts P.
    Inflamm Bowel Dis; 2012 Dec 07; 18(12):2218-24. PubMed ID: 22344983
    [Abstract] [Full Text] [Related]

  • 13. Role of fecal calprotectin as a biomarker of intestinal inflammation in inflammatory bowel disease.
    Konikoff MR, Denson LA.
    Inflamm Bowel Dis; 2006 Jun 07; 12(6):524-34. PubMed ID: 16775498
    [Abstract] [Full Text] [Related]

  • 14. Fecal calprotectin as a marker of the severity of mucosal inflammation in children with inflammatory bowel disease.
    Dolinšek J, Rižnik P, Sabath L, Mičetić-Turk D.
    Wien Klin Wochenschr; 2016 Apr 07; 128(7-8):253-9. PubMed ID: 26659704
    [Abstract] [Full Text] [Related]

  • 15. Fecal hemoglobin and calprotectin are equally effective in identifying patients with inflammatory bowel disease with active endoscopic inflammation.
    Mooiweer E, Fidder HH, Siersema PD, Laheij RJ, Oldenburg B.
    Inflamm Bowel Dis; 2014 Feb 07; 20(2):307-14. PubMed ID: 24374878
    [Abstract] [Full Text] [Related]

  • 16. Diagnostic work-up of inflammatory bowel disease in children: the role of calprotectin assay.
    Diamanti A, Panetta F, Basso MS, Forgione A, Colistro F, Bracci F, Papadatou B, Francalanci P, Torroni F, Knafelz D, Fina F, Castro M.
    Inflamm Bowel Dis; 2010 Nov 07; 16(11):1926-30. PubMed ID: 20310017
    [Abstract] [Full Text] [Related]

  • 17. Fecal calprotectin is an effective diagnostic tool that differentiates inflammatory from functional intestinal disorders.
    Caviglia GP, Pantaleoni S, Touscoz GA, Adriani A, Rosso C, Smedile A, Pellicano R, Astegiano M, Bresso F.
    Scand J Gastroenterol; 2014 Dec 07; 49(12):1419-24. PubMed ID: 25369978
    [Abstract] [Full Text] [Related]

  • 18. Calprotectin or Lactoferrin: Do They Help.
    Wright EK.
    Dig Dis; 2016 Dec 07; 34(1-2):98-104. PubMed ID: 26982329
    [Abstract] [Full Text] [Related]

  • 19. Fecal Calprotectin Is Not Affected by Pregnancy: Clinical Implications for the Management of Pregnant Patients with Inflammatory Bowel Disease.
    Julsgaard M, Hvas CL, Gearry RB, Vestergaard T, Fallingborg J, Svenningsen L, Kjeldsen J, Sparrow MP, Wildt S, Kelsen J, Bell SJ.
    Inflamm Bowel Dis; 2017 Jul 07; 23(7):1240-1246. PubMed ID: 28498159
    [Abstract] [Full Text] [Related]

  • 20. Noninvasive testing in the management of children with suspected inflammatory bowel disease.
    Dilillo D, Zuccotti GV, Galli E, Meneghin F, Dell'Era A, Penagini F, Colella G, Lewindon P, Carmagnola S, Farina E, Ardizzone S, Maconi G.
    Scand J Gastroenterol; 2019 May 07; 54(5):586-591. PubMed ID: 31032665
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.